Novo Nordisk's Wegovy Launch and U.S. Abortion Pill Battles: A Health News Overview
Published on: Jan. 5, 2026, 6:29 p.m. | Source: Devdiscourse
Novo Nordisk has launched Wegovy, a daily weight-loss pill, in the U.S. market, priced at $149 monthly. Simultaneously, the U.S. continues to face controversies over abortion pill access. Since the Supreme Court's 2022 decision, medication abortions have surged, igniting legal battles across the nation.
